Dallas Jayson Donald Alexander

Related Filers (4)

Ownership (38)

4
Wednesday, 6/15/2022
Galecto, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/11/2022
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/28/2021
Galecto, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2021
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/23/2020
Galecto, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 11/23/2020
Galecto, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/14/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/16/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/26/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/12/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/10/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/4/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
5
Friday, 2/14/2020
Aimmune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
4
Monday, 6/17/2019
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/26/2019
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/19/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/19/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/19/2018
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/15/2018
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/4/2018
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/19/2018
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/5/2018
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/7/2017
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/14/2017
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/1/2017
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/1/2017
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/14/2017
ARENA PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/14/2017
ARENA PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Monday, 8/8/2016
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/7/2016
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2016
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/6/2015
Ultragenyx Pharmaceutical Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 8/6/2015
Ultragenyx Pharmaceutical Inc.: Statement of changes in beneficial ownership of securities
Show More